Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
Studies demonstrate that methamphetamine (meth) use is associated with high-risk sexual
behavior among MSM, putting meth-using MSM at extraordinarily high risk for transmitting or
acquiring HIV. No studies have tested the feasibility and acceptability of conducting
pharmacologic interventions to reduce meth use and meth-associated sexual risk behavior among
MSM. The purpose of this pilot study is to determine the feasibility enrolling and retaining
meth-dependent MSM into a pharmacologic study of bupropion vs. placebo and measuring the
tolerability of and adherence to medication among these participants.
Phase:
Phase 2
Details
Lead Sponsor:
San Francisco Department of Public Health
Collaborators:
National Institute on Drug Abuse (NIDA) Public Health Foundation Enterprises, Inc.